Trial overview
death, COPD
COPD, SECONDARY
This was a two-arm, mixed method, single-blinded superiority randomized controlled comparative effectiveness trial where we collected 12-month longitudinal data. The hypothesis was that a referral to TelePR would lead to lower 6-month rehospitalization, or death compared to a referral to standard, office-based pulmonary rehabilitation (SPR). The secondary outcomes included changes from baseline to post-PR sessions (i.e., day 1 and 8-weeks) and tertiary outcomes included update and adherence to PR after referral, longitudinal changes (6- and 12-months) in symptoms and whether patients would continue to exercise. Figure SOutcomes were chosen based on the known effect of PR in COPD persons, and clinical relevance to patients and providers. Where available, we selected measures validated for use in both English/Spanish.